FDA Grants Orphan Drug Designation To GlycoMimetics' GMI-1271 For Treatment of Acute Myleogenous Leukemia
May 14, 2015 at 10:32 AM EDT
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation ...
